LOCALLY ADVANCED OR METASTATIC GASTRIC CANCER - NEW THERAPEUTIC SOLUTIONS

被引:0
作者
Patrascu, Florina [1 ]
Croitoru, Adina [1 ]
Gramaticu, Iulia [1 ]
Andrei, M. [3 ]
Teiutanu, Adriana [3 ]
Diculescu, M. [2 ]
机构
[1] ICBDTHF, Compartimentul Oncol Med, Bucharest, Romania
[2] ICBDTH Fundeni, Clin Gastroenterol & Hepatol, Bucharest, Romania
[3] SUU Elias, Clin Gastroenterol & Hepatol, Bucharest, Romania
来源
MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA | 2011年 / 115卷 / 01期
关键词
ADVANCED GASTRIC CANCER; CHEMOTHERAPY; RETROSPECTIVE STUDY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gastric cancer represents a major health problem worldwide. It is often diagnosed at an advanced stage, because screening, which would help an early detection is performed only in Japan. Gastric cancer rates may be decreased by reducing smoking and alcohol consumption and by increasing the number of fresh fruits and vegetables eaten. Eradication of Helicobacter pylori may also decrease gastric cancer incidence. Seventy-five percent of the patients are diagnosed in unresectable stage. They represent a challenge for clinicians as they have to choose between a strictly supportive approach or to expose patients to the side-effects of a potentially ineffective treatment. The treatment of advanced gastric cancer is essentially palliative. Therapy's main aim in this common group of patients with unresectable or metastatic disease is to achieve good symptomatic control, to improve quality of life, to avoid tumor progression and to prolong survival.
引用
收藏
页码:20 / 26
页数:7
相关论文
共 22 条
[1]  
Abrams AJ, 2010, SLEISENGER FORDTRANS, P887
[2]   Evolving chemotherapy for advanced gastric cancer [J].
Ajani, JA .
ONCOLOGIST, 2005, 10 :49-58
[3]  
Allum W. H., 2002, Gut, V50, pv1
[4]   Age-Specific Trends in Incidence of Noncardia Gastric Cancer in US Adults [J].
Anderson, William F. ;
Camargo, M. Constanza ;
Fraumeni, Joseph F., Jr. ;
Correa, Pelayo ;
Rosenberg, Philip S. ;
Rabkin, Charles S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (17) :1723-1728
[5]  
[Anonymous], 2009, CANC FACTS FIG
[6]   Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma [J].
Assersohn, L ;
Brown, G ;
Cunningham, D ;
Ward, C ;
Oates, J ;
Waters, JS ;
Hill, ME ;
Norman, AR .
ANNALS OF ONCOLOGY, 2004, 15 (01) :64-69
[7]   Weekly irinotecan in patients with metastatic gastric cancer failing cisplatin-based chemotherapy [J].
Chun, JH ;
Kim, HK ;
Lee, JS ;
Choi, JY ;
Lee, HG ;
Yoon, SM ;
Choi, IJ ;
Ryu, KW ;
Kim, YW ;
Bae, JM .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (01) :8-13
[8]   Capecitabine and oxaliplatin for advanced esophagogastric cancer [J].
Cunningham, David ;
Starling, Naureen ;
Rao, Sheela ;
Iveson, Timothy ;
Nicolson, Marianne ;
Coxon, Fareeda ;
Middleton, Gary ;
Daniel, Francis ;
Oates, Jacqueline ;
Norman, Andrew Richard .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (01) :36-46
[9]   Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].
Cunningham, David ;
Allum, William H. ;
Stenning, Sally P. ;
Thompson, Jeremy N. ;
Van de Velde, Cornelis J. H. ;
Nicolson, Marianne ;
Scarffe, J. Howard ;
Lofts, Fiona J. ;
Falk, Stephen J. ;
Iveson, Timothy J. ;
Smith, David B. ;
Langley, Ruth E. ;
Verma, Monica ;
Weeden, Simon ;
Chua, Yu Jo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20
[10]  
Fiori E, 2004, ANTICANCER RES, V24, P269